Mechanisms of amyloid fibril formation - Focus on domain-swapping

FEBS Journal

Volumn 278, Issue 13, 2011, Pages 2263-2282

  Zerovnik, Eva ^a   Stoka, Veronika ^a   Mirtič, Andreja ^b   Gunčar, Gregor ^c   Grdadolnik, Jože ^b,d   Staniforth, Rosemary A ^e   Turk, Dušan ^a,f   Turk, Vito ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d EN FIST CENTRE OF EXCELLENCE   (Slovenia)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

^f Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP)   (Slovenia)

Author keywords

domain swapping; mechanisms of amyloid fibril formation; protein aggregation; stefin B; toxic oligomers

Indexed keywords

AMYLOID; CYSTATIN; OLIGOMER; PROLINE; STEFIN;

AMINO ACID SUBSTITUTION; COLLOID; CONFORMATIONAL TRANSITION; DIPOLE; HUMAN; ISOMERIZATION; MOLECULAR MECHANICS; MOLECULAR MODEL; MORPHOLOGICAL TRAIT; NONHUMAN; OLIGOMERIZATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; REVIEW; STRUCTURE ANALYSIS;

AMYLOID; ANIMALS; HUMANS; MODELS, MOLECULAR; PROLINE; PROTEIN STRUCTURE, TERTIARY;

EID: 79959295755     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08149.x     Document Type: Review

References (187)

1. Irvine GB, El-Agnaf OM, Shankar GM, &, Walsh DM, (2008) Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases. Mol Med 14, 451-464.
2. Morris AM, Watzky MA, &, Finke RG, (2009) Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature. Biochim Biophys Acta 1794, 375-397.
3. Ross CA, &, Poirier MA, (2004) Protein aggregation and neurodegenerative disease. Nat Med 10 (Suppl), S10-S17. (Pubitemid 38901862)
4. Uversky VN, (2010) Mysterious oligomerization of the amyloidogenic proteins. FEBS J 277, 2940-2953.
5. Almeida CG, Takahashi RH, &, Gouras GK, (2006) Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J Neurosci 26, 4277-4288. (Pubitemid 44315387)
6. Ross CA, &, Pickart CM, (2004) The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases. Trends Cell Biol 14, 703-711. (Pubitemid 39572556)
7. Bush AI, &, Tanzi RE, (2008) Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics 5, 421-432. (Pubitemid 351952485)
8. Duce JA, &, Bush AI, (2010) Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics. Prog Neurobiol 92, 1-18.
9. Vernace VA, Schmidt-Glenewinkel T, &, Figueiredo-Pereira ME, (2007) Aging and regulated protein degradation: who has the UPPer hand? Aging Cell 6, 599-606. (Pubitemid 47400042)
10. Wong E, &, Cuervo AM, (2010) Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 13, 805-811.
11. +-controlled protein glycation. Adv Clin Chem 50, 123-150.
12. Uversky VN, &, Fink AL, (2005) Pathways to Amyloid Fibril Formation: Partially Folded Intermediates in the Fibril Formation of Natively Unfolded Proteins. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
13. Uversky VN, Li J, &, Fink AL, (2001) Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J Biol Chem 276, 10737-10744. (Pubitemid 38089246)
14. Dobson CM, (2002) Protein-misfolding diseases: getting out of shape. Nature 418, 729-730.
15. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, &, Glabe CG, (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489. (Pubitemid 36444329)
16. Jang H, Zheng J, &, Nussinov R, (2007) Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process. Biophys J 93, 1938-1949. (Pubitemid 47437578)
17. Lashuel HA, &, Lansbury PT, (2006) Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q Rev Biophys 39, 167-201. (Pubitemid 44711851)
18. Sahoo B, Balaji J, Nag S, Kaushalya SK, &, Maiti S, (2008) Protein aggregation probed by two-photon fluorescence correlation spectroscopy of native tryptophan. J Chem Phys 129, 075103.
19. Sipe JD, (2005) The β -Pleated Sheet Conformation and Protein Folding: A Brief History. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
20. Sunde M, &, Blake CCF, (1998) From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q Rev Biophys 31, 1-39. (Pubitemid 28379176)
21. Langkilde AE, &, Vestergaard B, (2009) Methods for structural characterization of prefibrillar intermediates and amyloid fibrils. FEBS Lett 583, 2600-2609.
22. Goldsbury C, Frey P, Olivieri V, Aebi U, &, Muller SA, (2005) Multiple assembly pathways underlie amyloid-beta fibril polymorphisms. J Mol Biol 352, 282-298. (Pubitemid 41213315)
23. Kad NM, Thomson NH, Smith DP, Smith DA, &, Radford SE, (2001) beta(2)-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. J Mol Biol 313, 559-571. (Pubitemid 33052287)
24. Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP, &, Tycko R, (2005) Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307, 262-265. (Pubitemid 40116242)
25. Tycko R, (2006) Molecular structure of amyloid fibrils: insights from solid-state NMR. Q Rev Biophys 39, 1-55. (Pubitemid 44566373)
26. Hoshino M, Katou H, Hagihara Y, Hasegawa K, Naiki H, &, Goto Y, (2002) Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. Nat Struct Biol 9, 332-336. (Pubitemid 34462549)
27. Yu L, Edalji R, Harlan JE, Holzman TF, Lopez AP, Labkovsky B, Hillen H, Barghorn S, Ebert U, Richardson PL, et al. (2009) Structural characterization of a soluble amyloid beta-peptide oligomer. Biochemistry 48, 1870-1877.
28. Glabe CG, (2008) Structural classification of toxic amyloid oligomers. J Biol Chem 283, 29639-29643.
29. Armen RS, DeMarco ML, Alonso DO, &, Daggett V, (2004) Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease. Proc Natl Acad Sci USA 101, 11622-11627. (Pubitemid 39095346)
30. Gething MJ, &, Sambrook J, (1992) Protein folding in the cell. Nature 33, 355.
31. Ellis RJ, &, Hartl FU, (1999) Principles of folding in the cellular environment. Curr Opin Struct Biol 9, 102.
32. Arimon M, Grimminger V, Sanz F, &, Lashuel HA, (2008) Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils. J Mol Biol 384, 1157-1173.
33. Glover JR, &, Lum R, (2009) Remodeling of protein aggregates by Hsp104. Protein Pept Lett 16, 587-597.
34. Vashist S, Cushman M, &, Shorter J, (2010) Applying Hsp104 to protein-misfolding disorders. Biochem Cell Biol 88, 1-13.
35. Dill KA, (1990) Dominant forces in protein folding. Biochemistry 29, 7133-7155. (Pubitemid 20230041)
36. Kauzmann W, (1959) Factors in interpretation of protein denaturation. Adv Protein Chem 14, 1-63.
37. Avbelj F, &, Moult J, (1995) Role of electrostatic screening in determining protein main chain conformational preferences. Biochemistry 34, 755-764.
38. Brant DA, &, Flory PJ, (1965) The role of dipole interactionsin determining polypeptide conformation. J Am Chem Soc 87, 663-664.
39. Perutz MF, (1978) Electrostatic effects in proteins. Science 201, 1187-1191. (Pubitemid 9029234)
40. Klapper MH, (1971) On the nature of the protein interior. Biochim Biophys Acta 229, 557-566.
41. Richards FM, (1977) Areas, volumes, packing and protein structure. Annu Rev Biophys Bioeng 6, 151-176.
42. Schellman JA, (1955) The stability of hydrogen-bonded peptide structures in aqueous solution. CR Trav Lab Carlsberg Ser Chim 29, 230-259.
43. Stickle DF, Presta LG, Dill KA, &, Rose GD, (1992) Hydrogen bonding in globular proteins. J Mol Biol 226, 1143-1159.
44. Makhatadze GI, &, Privalov PL, (1993) Contribution of hydration to protein folding. I. The enthalpy of hydration. J Mol Biol 232, 639-659. (Pubitemid 23251184)
45. Wolfenden R, (1978) Interaction of the peptide bond with solvent water: a vapor Phase Analysis. Biochemistry 17, 201-204. (Pubitemid 8257970)
46. Avbelj F, &, Fele L, (1998) Role of main-chain electrostatics, hydrophobic effect and side-chain conformational entropy in determining the secondary structure of proteins. J Mol Biol 279, 665-684. (Pubitemid 28279472)
47. Avbelj F, Golič Grdadolnik S, Grdadolnik J, &, Baldwine LR, (2006) Intrinsic backbone preferences are fully present in blocked amino acids. Proc Natl Acad Sci USA 103, 1272-1277. (Pubitemid 43191155)
48. Grdadolnik J, Grdadolnik SG, &, Avbelj F, (2008) Determination of conformational preferences of dipeptides using vibrational spectroscopy. J Phys Chem B 112, 2712-2718. (Pubitemid 351472981)
49. Avbelj F, (2000) Amino acid conformational preferences and solvation of polar backbone atoms in peptides and proteins. J Mol Biol 300, 1335-1359.
50. Avbelj F, Luo P, &, Baldwin RL, (2000) Energetics of the interaction between water and the helical peptide group and its role in determining helix propensities. Proc Natl Acad Sci USA 97, 10786-10791.
51. Avbelj F, &, Baldwin RL, (2003) Role of backbone solvation and electrostatics in generating preferred peptide backbone conformations: distributions of phi. Proc Natl Acad Sci USA 100, 5742-5747. (Pubitemid 36576878)
52. Wu C, Lei XH, &, Duan Y, (2004) Formation of partially ordered oligomers of amyloidogenic hexapeptide (NFGAIL) in aqueous solution observed in molecular dynamics simulations. Biophys J 87, 3000-3009. (Pubitemid 40468560)
53. Gsponer J, Haberthur U, &, Caflisch A, (2003) The role of side-chain interactions in the early steps of aggregation: molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35. Proc Natl Acad Sci USA 100, 5154-5159. (Pubitemid 36542674)
54. Lopez de la Paz M, Goldie K, Zurdo J, Lacroix E, Dobson CM, Hoenger A, &, Serrano L, (2002) De novo designed peptide-based amyloid fibrils. Proc Natl Acad Sci USA 99, 16052-16057. (Pubitemid 35462747)
55. Aggeli A, Nyrkova IA, Bell M, Harding R, Carrick L, McLeish TCB, Semenov AN, &, Boden N, (2001) Hierarchical self-assembly of chiral rod-like molecules as a model for peptide β-sheet tapes, ribbons, fibrils, and fibers. Proc Natl Acad Sci USA 98, 11857-11862. (Pubitemid 32959792)
56. Krebs MR, Devlin GL, &, Donald AM, (2009) Amyloid fibril-like structure underlies the aggregate structure across the pH range for beta-lactoglobulin. Biophys J 96, 5013-5019.
57. Zhang S, &, Rich A, (1997) Direct conversion of an oligopeptide from a β-sheet to an α-helix: a model for amyloid formation. Proc Natl Acad Sci USA 94, 23-28. (Pubitemid 27027157)
58. Fernández A, (2005) What factor drives the fibrillogenic association of β-sheets? FEBS Lett 579, 6635-6640. (Pubitemid 41682451)
59. Kenig M, Jenko-Kokalj S, Tusek-Znidaric M, Pompe-Novak M, Guncar G, Turk D, Waltho JP, Staniforth RA, Avbelj F, &, Zerovnik E, (2006) Folding and amyloid-fibril formation for a series of human stefins' chimeras: any correlation? Proteins 62, 918-927. (Pubitemid 43364156)
60. Rabzelj S, Turk V, &, Zerovnik E, (2005) In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1. Protein Sci 14, 2713-2722. (Pubitemid 41395597)
61. Kelly JW, (1998) The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr Opin Struct Biol 8, 101-106. (Pubitemid 28107921)
62. Lansbury PT, (1999) Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc Natl Acad Sci USA 96, 3342-3344. (Pubitemid 29168913)
63. Rochet JC, &, Lansbury PT, (2000) Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 10, 60-68.
64. Zerovnik E, (2002) Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease. Eur J Biochem 269, 3362-3371. (Pubitemid 34988978)
65. Daizo H, &, Dobson CM, (2002) A kinetic study of b-lactoglobulin amyloid fibril formation promoted by urea. Protein Sci 11, 2417-2426.
66. Guijarro JI, Sunde M, Jones JA, Campbell ID, &, Dobson CM, (1998) Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci USA 95, 4224-4228. (Pubitemid 28207893)
67. Ramirez-Alvarado M, Merkel JS, &, Regan L, (2000) A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. Proc Natl Acad Sci USA 97, 8979-8984. (Pubitemid 30626659)
68. Bousset L, Thomson NH, Radford SE, &, Melki R, (2002) The yeast prion Ure2p retains its native α conformation upon assembly into protein fibrils. EMBO J 21, 2903-2911. (Pubitemid 34670375)
69. Laurine E, Gregoire C, Faendrich M, Engemann S, Marchal S, Thion L, Mohr M, Monsarrat B, Michel B, Dobson CM, et al. (2003) Lithostathine quadruple-helical filaments form proteinase K-resistant deposits in Creutzfeldt-Jakob disease. J Biol Chem 278, 51770-51778. (Pubitemid 38020423)
70. Fandrich M, Fletcher MA, &, Dobson CM, (2001) Amyloid fibrils from muscle myoglobin. Nature 410, 165-166.
71. Kallberg Y, Gustafsson M, Persson B, Thyberg J, &, Johansson J, (2001) Prediction of amyloid fibril-forming proteins. J Biol Chem 276, 12945-12950.
72. Bitan G, Vollers SS, &, Teplow DB, (2003) Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization. J Biol Chem 278, 34882-34889. (Pubitemid 37102247)
73. Collins SR, Douglass A, Vale RD, &, Weissman JS, (2004) Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol 2, 1582-1590.
74. Hess S, Lindquist SL, &, Scheibel T, (2007) Alternative assembly pathways of the amyloidogenic yeast prion determinant Sup35-NM. EMBO Rep 8, 1196-1201. (Pubitemid 350201740)
75. Kumar S, &, Udgaonkar JB, (2009) Conformational conversion may precede or follow aggregate elongation on alternative pathways of amyloid protofibril formation. J Mol Biol 385, 1266-1276.
76. Thakur AK, Jayaraman M, Mishra R, Thakur M, Chellgren VM, Byeon IJ, Anjum DH, Kodali R, Creamer TP, Conway JF, et al. (2009) Polyglutamine disruption of the Huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol 16, 380-389.
77. Heise H, Hoyer W, Becker S, Andronesi OC, Riedel D, &, Baldus M, (2005) Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. Proc Natl Acad Sci USA 102, 15871-15876. (Pubitemid 41552835)
78. Kad NM, Myers SL, Smith DP, Smith DA, Radford SE, &, Thomson NH, (2003) Hierarchical assembly of beta(2)-microglobulin amyloid in vitro revealed by atomic force microscopy. J Mol Biol 330, 785-797.
79. Richardson JS, &, Richardson DC, (2002) Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci USA 99, 2754-2759. (Pubitemid 34240533)
80. Chiti F, Stefani M, Taddei N, Ramponi G, &, Dobson CM, (2003) Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424, 805-808. (Pubitemid 37021713)
81. Pawar AP, Dubay KF, Zurdo J, Chiti F, Vendruscolo M, &, Dobson CM, (2005) Prediction of 'aggregation-prone' and 'aggregation-susceptible' regions in proteins associated with neurodegenerative diseases. J Mol Biol 350, 379-392. (Pubitemid 40805470)
82. Ventura S, Zurdo J, Narayanan S, Parreno M, Mangues R, Reif B, Chiti F, Giannoni E, Dobson CM, Aviles FX, et al. (2004) Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci USA 101, 7258-7263. (Pubitemid 38638020)
83. Conchillo-Sole O, de Groot NS, Aviles FX, Vendrell J, Daura X, &, Ventura S, (2007) AGGRESCAN: a server for the prediction and evaluation of 'hot spots' of aggregation in polypeptides. BMC Bioinformatics 8, 65.
84. Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, &, Serrano L, (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 22, 1302-1306. (Pubitemid 39336784)
85. Thompson MJ, Sievers SA, Karanicolas J, Ivanova MI, Baker D, &, Eisenberg D, (2006) The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci USA 103, 4074-4078.
86. Goldschmidt L, Teng PK, Riek R, &, Eisenberg D, (2010) Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc Natl Acad Sci USA 107, 3487-3492.
87. Kelly JW, (2000) Mechanisms of amyloidogenesis. Nat Struct Biol 7, 824-826.
88. Bhak G, Choe YJ, &, Paik SR, (2009) Mechanism of amyloidogenesis: nucleation-dependent fibrillation versus double-concerted fibrillation. BMB Rep 42, 541-551.
89. Hamada D, Tanaka T, Tartaglia GG, Pawar A, Vendruscolo M, Kawamura M, Tamura A, Tanaka N, &, Dobson CM, (2009) Competition between folding, native-state dimerisation and amyloid aggregation in beta-lactoglobulin. J Mol Biol 386, 878-890.
90. Merlini G, &, Bellotti V, (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349, 583-596. (Pubitemid 36951371)
91. Griffith JS, (1967) Self-replication and scrapie. Nature 215, 1043-1044.
92. Prusiner SB, (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144. (Pubitemid 12089840)
93. Perutz MF, Staden R, Moens L, &, De Baere I, (1993) Polar zippers. Curr Biol 3, 249-253.
94. Perutz M, (1994) Polar zippers: their role in human disease. Protein Sci 3, 1629-1637. (Pubitemid 24356586)
95. Perutz MF, Johnson T, Suzuki M, &, Finch JT, (1994) Glutamine repeats as polar zippers-their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci USA 91, 5355-5358. (Pubitemid 24174325)
96. Michelitsch MD, &, Weissman JS, (2000) A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions. Proc Natl Acad Sci USA 97, 11910-11915.
97. Jarrett JT, &, Lansbury PT Jr, (1993) Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058. (Pubitemid 23180480)
98. Serio TR, Cashikar AG, Kowal AS, Sawicki GJ, Moslehi JJ, Serpell L, Arnsdorf MF, &, Lindquist SL, (2000) Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289, 1317-1321. (Pubitemid 30656041)
99. Wood SJ, Wypych J, Steavenson S, Louis JC, Citron M, &, Biere AL, (1999) alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J Biol Chem 274, 19509-19512.
100. Lomakin A, Teplow DB, Kirschner DA, &, Benedek GB, (1997) Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci USA 94, 7942-7947. (Pubitemid 27343754)
101. Hellstrand E, Boland B, Walsh DM, &, Linse S, (2010) Amyloid beta-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem Neurosci 1, 13-18.
102. Kumar S, &, Udgaonkar JB, (2010) Mechanisms of amyloid fibril formation by proteins. Curr Sci India 98, 639-656.
103. DePace AH, Santoso A, Hillner P, &, Weissman JS, (1998) A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93, 1241-1252. (Pubitemid 28307428)
104. Modler AJ, Gast K, Lutsch G, &, Damaschun G, (2003) Assembly of amyloid protofibrils via critical oligomers-a novel pathway of amyloid formation. J Mol Biol 325, 135-148. (Pubitemid 36153003)
105. Damaschun G, Damaschun H, Gast K, &, Zirwer D, (1999) Proteins can adopt totally different folded conformations. J Mol Biol 291, 715-725. (Pubitemid 29392646)
106. Damaschun G, Damaschun H, Fabian H, Gast K, Krober R, Wieske M, &, Zirwer D, (2000) Conversion of yeast phosphoglycerate kinase into amyloid-like structure. Proteins 39, 204-211. (Pubitemid 30226501)
107. Xu SH, Bevis B, &, Arnsdorf MF, (2001) The assembly of amyloidogenic yeast Sup35 as assessed by scanning (atomic) force microscopy: an analogy to linear colloidal aggregation? Biophys J 81, 446-454. (Pubitemid 32605983)
108. Bhak G, Lee JH, Hahn JS, &, Paik SR, (2009) Granular assembly of alpha-synuclein leading to the accelerated amyloid fibril formation with shear stress. PLoS ONE 4, e4177.
109. Kordis D, &, Turk V, (2009) Phylogenomic analysis of the cystatin superfamily in eukaryotes and prokaryotes. BMC Evol Biol 9, 266.
110. Turk V, Stoka V, &, Turk D, (2008) Cystatins: biochemical and structural properties, and medical relevance. Front Biosci 13, 5406-5420.
111. Palsdottir A, Abrahamson M, Thorsteinsson L, Arnason A, Olafsson I, Grubb A, &, Jensson O, (1988) Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 2, 603-604.
112. Tizon B, Sahoo S, Yu H, Gauthier S, Kumar AR, Mohan P, Figliola M, Pawlik M, Grubb A, Uchiyama Y, et al. (2010) Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines. PLoS ONE 5, e9819.
113. Benussi L, Ghidoni R, Galimberti D, Boccardi M, Fenoglio C, Scarpini E, Frisoni GB, &, Binetti G, (2010) The CST3 B haplotype is associated with frontotemporal lobar degeneration. Eur J Neurol 17, 143-146.
114. Benussi L, Ghidoni R, Steinhoff T, Alberici A, Villa A, Mazzoli F, Nicosia F, Barbiero L, Broglio L, Feudatari E, et al. (2003) Alzheimer disease-associated cystatin C variant undergoes impaired secretion. Neurobiol Dis 13, 15-21. (Pubitemid 36561594)
115. Ii K, Ito H, Kominami E, &, Hirano A, (1993) Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged. Virchows Arch A Pathol Anat Histopathol 423, 185-194. (Pubitemid 23309333)
116. Lalioti MD, Mirotsou M, Buresi C, Peitsch MC, Rossier C, Ouazzani R, Baldy-Moulinier M, Bottani A, Malafosse A, &, Antonarakis SE, (1997) Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1). Am J Hum Genet 60, 342-351. (Pubitemid 27058405)
117. Pennacchio LA, Lehesjoki AE, Stone NE, Willour VL, Virtaneva K, Miao J, D'Amato E, Ramirez L, Faham M, Koskiniemi M, et al. (1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271, 1731-1734. (Pubitemid 26102822)
118. Pennacchio LA, Bouley DM, Higgins KM, Scott MP, Noebels JL, &, Myers RM, (1998) Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat Genet 20, 251-258. (Pubitemid 28507669)
119. Lehtinen MK, Tegelberg S, Schipper H, Su H, Zukor H, Manninen O, Kopra O, Joensuu T, Hakala P, Bonni A, et al. (2009) Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1. J Neurosci 29, 5910-5915.
120. Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M, &, Jaskolski M, (2001) Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol 8, 316-320. (Pubitemid 32275015)
121. Jerala R, &, Zerovnik E, (1999) Accessing the global minimum conformation of stefin A dimer by annealing under partially denaturing conditions. J Mol Biol 291, 1079-1089. (Pubitemid 29423771)
122. Staniforth RA, Giannini S, Higgins LD, Conroy MJ, Hounslow AM, Jerala R, Craven CJ, &, Waltho JP, (2001) Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J 20, 4774-4781. (Pubitemid 32848630)
123. Jenko Kokalj S, Guncar G, Stern I, Morgan G, Rabzelj S, Kenig M, Staniforth RA, Waltho JP, Zerovnik E, &, Turk D, (2007) Essential role of proline isomerization in stefin B tetramer formation. J Mol Biol 366, 1569-1579. (Pubitemid 46215609)
124. Zerovnik E, Turk V, &, Waltho JP, (2002) Amyloid fibril formation by human stefin B: influence of the initial pH-induced intermediate state. Biochem Soc Trans 30, 543-547. (Pubitemid 35001595)
125. Jenko S, Skarabot M, Kenig M, Guncar G, Musevic I, Turk D, &, Zerovnik E, (2004) Different propensity to form amyloid fibrils by two homologous proteins-Human stefins A and B: searching for an explanation. Proteins 55, 417-425. (Pubitemid 38437497)
126. Zerovnik E, Skarabot M, Skerget K, Giannini S, Stoka V, Jenko-Kokalj S, &, Staniforth RA, (2007) Amyloid fibril formation by human stefin B: influence of pH and TFE on fibril growth and morphology. Amyloid 14, 237-247. (Pubitemid 47262696)
127. Zerovnik E, Pompe-Novak M, Skarabot M, Ravnikar M, Musevic I, &, Turk V, (2002) Human stefin B readily forms amyloid fibrils in vitro. Biochim Biophys Acta 1594, 1-5. (Pubitemid 34131720)
128. Staniforth RA, Dean JL, Zhong Q, Zerovnik E, Clarke AR, &, Waltho JP, (2000) The major transition state in folding need not involve the immobilization of side chains. Proc Natl Acad Sci USA 97, 5790-5795. (Pubitemid 30367477)
129. Zerovnik E, Virden R, Jerala R, Kroon-Zitko L, Turk V, &, Waltho JP, (1999) Differences in the effects of TFE on the folding pathways of human stefins A and B. Proteins 36, 205-216. (Pubitemid 29305089)
130. Miller KH, Karr JR, &, Marqusee S, (2010) A hinge region cis-proline in ribonuclease A acts as a conformational gatekeeper for C-terminal domain swapping. J Mol Biol 400, 567-578.
131. Ferreira ST, &, De Felice FG, (2001) PABMB Lecture. Protein dynamics, folding and misfolding: from basic physical chemistry to human conformational diseases. FEBS Lett 498, 129-134. (Pubitemid 32539189)
132. Liu Y, &, Eisenberg D, (2002) 3D domain swapping: as domains continue to swap. Protein Sci 11, 1285-1299. (Pubitemid 34547201)
133. Knaus KJ, Morillas M, Swietnicki W, Malone M, Surewicz WK, &, Yee VC, (2001) Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol 8, 770-774. (Pubitemid 32803594)
134. Serag AA, Altenbach C, Gingery M, Hubbell WL, &, Yeates TO, (2001) Identification of a subunit interface in transthyretin amyloid fibrils: evidence for self-assembly from oligomeric building blocks. Biochemistry 40, 9089-9096. (Pubitemid 32730029)
135. Sabate R, Gallardo M, &, Estelrich J, (2005) Temperature dependence of the nucleation constant rate in beta amyloid fibrillogenesis. Int J Biol Macromol 35, 9-13. (Pubitemid 40354208)
136. Auer S, Dobson CM, &, Vendruscolo M, (2007) Characterization of the nucleation barriers for protein aggregation and amyloid formation. HFSP J 1, 137-146.
137. Skerget K, Vilfan A, Pompe-Novak M, Turk V, Waltho JP, Turk D, &, Zerovnik E, (2009) The mechanism of amyloid-fibril formation by stefin B: temperature and protein concentration dependence of the rates. Proteins 74, 425-436.
138. Nilsson M, Wang X, Rodziewicz-Motowidlo S, Janowski R, Lindstrom V, Onnerfjord P, Westermark G, Grzonka Z, Jaskolski M, &, Grubb A, (2004) Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C: use of engineered disulfide bridges, antibodies, and carboxymethylpapain to stabilize the monomeric form of cystatin C. J Biol Chem 279, 24236-24245. (Pubitemid 38725285)
139. Laganowsky A, &, Eisenberg D, (2010) Non-3D domain swapped crystal structure of truncated zebrafish alphaA crystallin. Protein Sci 19, 1978-1984.
140. Gotte G, Vottariello F, &, Libonati M, (2003) Thermal aggregation of ribonuclease A. A contribution to the understanding of the role of 3D domain swapping in protein aggregation. J Biol Chem 278, 10763-10769. (Pubitemid 36800348)
141. Rousseau F, Schymkowitz JW, Wilkinson HR, &, Itzhaki LS, (2001) Three-dimensional domain swapping in p13suc1 occurs in the unfolded state and is controlled by conserved proline residues. Proc Natl Acad Sci USA 98, 5596-5601. (Pubitemid 32435687)
142. Stubbs MT, Laber B, Bode W, Huber R, Jerala R, Lenarcic B, &, Turk V, (1990) The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J 9, 1939-1947.
143. Smajlovic A, Berbic S, Schiene-Fischer C, Tusek-Znidaric M, Taler A, Jenko-Kokalj S, Turk D, &, Zerovnik E, (2009) Essential role of Pro 74 in stefin B amyloid-fibril formation: dual action of cyclophilin A on the process. FEBS Lett 583, 1114-1120.
144. Eakin CM, Attenello FJ, Morgan CJ, &, Miranker AD, (2004) Oligomeric assembly of native-like precursors precedes amyloid formation by beta-2 microglobulin. Biochemistry 43, 7808-7815. (Pubitemid 38787688)
145. Eakin CM, Berman AJ, &, Miranker AD, (2006) A native to amyloidogenic transition regulated by a backbone trigger. Nat Struct Mol Biol 13, 202-208. (Pubitemid 43348505)
146. Jahn TR, Parker MJ, Homans SW, &, Radford SE, (2006) Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nat Struct Mol Biol 13, 195-201. (Pubitemid 43348504)
147. Blaho DV, &, Miranker AD, (2009) Delineating the conformational elements responsible for Cu(2+)-induced oligomerization of beta-2 microglobulin. Biochemistry 48, 6610-6617.
148. Calabrese MF, Eakin CM, Wang JM, &, Miranker AD, (2008) A regulatable switch mediates self-association in an immunoglobulin fold. Nat Struct Mol Biol 15, 965-971.
149. Zerovnik E, Skerget K, Tusek-Znidaric M, Loeschner C, Brazier MW, &, Brown DR, (2006) High affinity copper binding by stefin B (cystatin B) and its role in the inhibition of amyloid fibrillation. FEBS J 273, 4250-4263. (Pubitemid 44326505)
150. Bennett MJ, Schlunegger MP, &, Eisenberg D, (1995) 3D domain swapping: a mechanism for oligomer assembly. Protein Sci 4, 2455-2468.
151. Liu Y, Gotte G, Libonati M, &, Eisenberg D, (2001) A domain-swapped RNase A dimer with implications for amyloid formation. Nat Struct Biol 8, 211-214. (Pubitemid 32180044)
152. Janowski R, Abrahamson M, Grubb A, &, Jaskolski M, (2004) Domain swapping in N-truncated human cystatin C. J Mol Biol 341, 151-160. (Pubitemid 39090641)
153. Janowski R, Kozak M, Abrahamson M, Grubb A, &, Jaskolski M, (2005) 3D domain-swapped human cystatin C with amyloidlike intermolecular beta-sheets. Proteins 61, 570-578. (Pubitemid 41547413)
154. Zerovnik E, Staniforth RA, &, Turk D, (2010) Amyloid fibril formation by human stefins: structure, mechanism & putative functions. Biochimie 92, 1597-1607.
155. Sanders A, Jeremy Craven C, Higgins LD, Giannini S, Conroy MJ, Hounslow AM, Waltho JP, &, Staniforth RA, (2004) Cystatin forms a tetramer through structural rearrangement of domain-swapped dimers prior to amyloidogenesis. J Mol Biol 336, 165-178. (Pubitemid 38102338)
156. Nordlund A, &, Oliveberg M, (2006) Folding of Cu/Zn superoxide dismutase suggests structural hotspots for gain of neurotoxic function in ALS: parallels to precursors in amyloid disease. Proc Natl Acad Sci USA 103, 10218-10223. (Pubitemid 44051147)
157. Newcomer ME, (2002) Protein folding and three-dimensional domain swapping: a strained relationship? Curr Opin Struct Biol 12, 48-53. (Pubitemid 34142720)
158. Ogihara NL, Ghirlanda G, Bryson JW, Gingery M, DeGrado WF, &, Eisenberg D, (2001) Design of three-dimensional domain-swapped dimers and fibrous oligomers. Proc Natl Acad Sci USA 98, 1404-1409. (Pubitemid 32165511)
159. Rousseau F, Schymkowitz J, &, Itzhaki LS, (2007) Implications of 3D domain swapping for protein folding, misfolding and function. In Protein
160. Guo Z, &, Eisenberg D, (2006) Runaway domain swapping in amyloid-like fibrils of T7 endonuclease I. Proc Natl Acad Sci USA 103, 8042-8047. (Pubitemid 43801049)
161. Liu C, Sawaya MR, &, Eisenberg D, (2011) Beta-microglobulin forms three-dimensional domain-swapped amyloid fibrils with disulfide linkages. Nat Struct Mol Biol 18, 49-55.
162. Wahlbom M, Wang X, Lindstrom V, Carlemalm E, Jaskolski M, &, Grubb A, (2007) Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping. J Biol Chem 282, 18318-18326. (Pubitemid 47100211)
163. Morgan GJ, Giannini S, Hounslow AM, Craven CJ, Zerovnik E, Turk V, Waltho JP, &, Staniforth RA, (2008) Exclusion of the native alpha-helix from the amyloid fibrils of a mixed alpha/beta protein. J Mol Biol 375, 487-498. (Pubitemid 350192480)
164. Nilsson MR, &, Raleigh DP, (1999) Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin. J Mol Biol 294, 1375-1385. (Pubitemid 30008807)
165. Kolodziejczyk R, Michalska K, Hernandez-Santoyo A, Wahlbom M, Grubb A, &, Jaskolski M, (2010) Crystal structure of human cystatin C stabilized against amyloid formation. Febs J 277, 1726-1737.
166. Zerovnik E, Zavasnik-Bergant V, Kopitar-Jerala N, Pompe-Novak M, Skarabot M, Goldie K, Ravnikar M, Musevic I, &, Turk V, (2002) Amyloid fibril formation by human stefin B in vitro: immunogold labelling and comparison to stefin A. Biol Chem 383, 859-863. (Pubitemid 34649907)
167. Pallitto MM, &, Murphy RM, (2001) A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys J 81, 1805-1822. (Pubitemid 32783616)
168. Powers ET, &, Powers DL, (2008) Mechanisms of protein fibril formation: nucleated polymerization with competing off-pathway aggregation. Biophys J 94, 379-391.
169. Ceru S, Kokalj SJ, Rabzelj S, Skarabot M, Gutierrez-Aguirre I, Kopitar-Jerala N, Anderluh G, Turk D, Turk V, &, Zerovnik E, (2008) Size and morphology of toxic oligomers of amyloidogenic proteins: a case study of human stefin B. Amyloid 15, 147-159.
170. Horwich A, (2002) Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions. J Clin Invest 110, 1221-1232. (Pubitemid 35285746)
171. Wetzel R, (1996) For protein misassembly, it's the 'I' decade. Cell 86, 699-702. (Pubitemid 26303438)
172. Ceru S, &, Zerovnik E, (2008) Similar toxicity of the oligomeric molten globule state and the prefibrillar oligomers. FEBS Lett 582, 203-209.
173. Uversky VN, (2002) Natively unfolded proteins: a point where biology waits for physics. Protein Sci 11, 739-756. (Pubitemid 34241284)
174. Uversky VN, (2009) Intrinsic disorder in proteins associated with neurodegenerative diseases. Front Biosci 14, 5188-5238.
175. Uversky VN, &, Fink AL, (2004) Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta 1698, 131-153. (Pubitemid 38591469)
176. Harper JD, &, Lansbury PT Jr, (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66, 385-407. (Pubitemid 27274662)
177. Ross CA, Wood JD, Schilling G, Peters MF, Nucifora FC Jr, Cooper JK, Sharp AH, Margolis RL, &, Borchelt DR, (1999) Polyglutamine pathogenesis. Philos Trans R Soc Lond B Biol Sci 354, 1005-1011. (Pubitemid 29477961)
178. Dahlgren PR, Karymov MA, Bankston J, Holden T, Thumfort P, Ingram VM, &, Lyubchenko YL, (2005) Atomic force microscopy analysis of the Huntington protein nanofibril formation. Nanomedicine 1, 52-57. (Pubitemid 43963606)
179. Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R, Bates GP, Lehrach H, &, Wanker EE, (1999) Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc Natl Acad Sci USA 96, 4604-4609. (Pubitemid 29190383)
180. Pellarin R, &, Caflisch A, (2006) Interpreting the aggregation kinetics of amyloid peptides. J Mol Biol 360, 882-892.
181. Chan HS, &, Dill KA, (1998) Protein folding in the landscape perspective: chevron plots and non-Arrhenius kinetics. Proteins 30, 2-33. (Pubitemid 28036107)
182. Lummis SC, Beene DL, Lee LW, Lester HA, Broadhurst RW, &, Dougherty DA, (2005) Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel. Nature 438, 248-252. (Pubitemid 41599879)
183. Ryo A, Togo T, Nakai T, Hirai A, Nishi M, Yamaguchi A, Suzuki K, Hirayasu Y, Kobayashi H, Perrem K, et al. (2006) Prolyl-isomerase Pin1 accumulates in lewy bodies of parkinson disease and facilitates formation of alpha-synuclein inclusions. J Biol Chem 281, 4117-4125. (Pubitemid 43847838)
184. Pastorino L, Sun A, Lu PJ, Zhou XZ, Balastik M, Finn G, Wulf G, Lim J, Li SH, Li X, et al. (2006) The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 440, 528-534.
185. Carrotta R, Manno M, Bulone D, Martorana V, &, San Biagio PL, (2005) Protofibril formation of amyloid beta-protein at low pH via a non-cooperative elongation mechanism. J Biol Chem 280, 30001-30008. (Pubitemid 41216175)
186. Jaskolski M, (2001) 3D domain swapping, protein oligomerization, and amyloid formation. Acta Biochim Pol 48, 807-827. (Pubitemid 33602339)
187. Lee JH, Bhak G, Lee SG, &, Paik SR, (2008) Instantaneous amyloid fibril formation of alpha-synuclein from the oligomeric granular structures in the presence of hexane. Biophys J 95, L16-L18.